← Evidence map

ArticleCommunications medicine2025

Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study.

Martina Patone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025

this papercites it

Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study. | OpenQuestion